Literature DB >> 10987374

High suicidal ideation in persons testing for Huntington's disease.

T B Robins Wahlin1, L Bäckman, A Lundin, A Haegermark, B Winblad, M Anvret.   

Abstract

This study examined the first participants who registered for the Huntington's disease predictive testing program 1990-1995 in Stockholm, Sweden. A psychosocial investigation was performed to evaluate potential effects of the presymptomatic testing. The results showed no significant differences between 13 gene carriers and 21 noncarriers in pretest attitudes, expectations, general well-being, life satisfaction and lifestyle, the need for support, estimated sense of wellbeing or degree of health. However, both groups showed high suicidal ideation and self-injurious behavior. Noncarriers had a very high frequency of attempted suicide, and both groups had similarly pronounced psychiatric dysfunction. Their relatives also had high frequencies of psychiatric diseases, suicide or suicidal attempts. Most of the participants had a desire to meet a psychologist or a social worker. The need for counseling, using a well designed protocol, and the importance of focusing on suicide risk of participants in predictive testing programs is emphasized.

Entities:  

Mesh:

Year:  2000        PMID: 10987374     DOI: 10.1034/j.1600-0404.2000.102003150.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  15 in total

Review 1.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  Prenatal whole genome sequencing: just because we can, should we?

Authors:  Greer Donley; Sara Chandros Hull; Benjamin E Berkman
Journal:  Hastings Cent Rep       Date:  2012-06-20       Impact factor: 2.683

3.  Depression and suicidal ideation after predictive testing for Huntington's disease: a two-year follow-up study.

Authors:  Maria U Larsson; Mary A Luszcz; The-Hung Bui; Tarja-Brita Robins Wahlin
Journal:  J Genet Couns       Date:  2006-10       Impact factor: 2.537

Review 4.  How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review.

Authors:  Stephanie Sivell; Glyn Elwyn; Clara L Gaff; Angus J Clarke; Rachel Iredale; Chris Shaw; Joanna Dundon; Hazel Thornton; Adrian Edwards
Journal:  J Genet Couns       Date:  2007-10-30       Impact factor: 2.537

5.  Nationwide survey on predictive genetic testing for late-onset, incurable neurological diseases in Japan.

Authors:  Kunihiro Yoshida; Takahito Wada; Akihiro Sakurai; Keiko Wakui; Shu-Ichi Ikeda; Yoshimitsu Fukushima
Journal:  J Hum Genet       Date:  2007-07-05       Impact factor: 3.172

6.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

7.  Suicidal ideation in Huntington disease: the role of comorbidity.

Authors:  Heather H Wetzel; Carissa R Gehl; Lisa Dellefave-Castillo; Judith F Schiffman; Kathleen M Shannon; Jane S Paulsen
Journal:  Psychiatry Res       Date:  2011-05-24       Impact factor: 3.222

Review 8.  The psychological impact of predictive genetic testing for Huntington's disease: a systematic review of the literature.

Authors:  S Crozier; N Robertson; M Dale
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

9.  Suicide in Neurologic Illness.

Authors:  David B. Arciniegas; C. Alan Anderson
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

10.  Long-term outcome of presymptomatic testing in Huntington disease.

Authors:  Marcela Gargiulo; Séverine Lejeune; Marie-Laure Tanguy; Khadija Lahlou-Laforêt; Anne Faudet; David Cohen; Josué Feingold; Alexandra Durr
Journal:  Eur J Hum Genet       Date:  2008-08-20       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.